BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18006491)

  • 1. Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffness.
    Van den Bergh A; Vanderper A; Vangheluwe P; Desjardins F; Nevelsteen I; Verreth W; Wuytack F; Holvoet P; Flameng W; Balligand JL; Herijgers P
    Cardiovasc Res; 2008 Jan; 77(2):371-9. PubMed ID: 18006491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-restriction in obese dyslipidaemic diabetic mice partially restores basal contractility but not contractile reserve.
    Van den Bergh A; Vangheluwe P; Vanderper A; Carmeliet P; Wuytack F; Janssens S; Flameng W; Holvoet P; Herijgers P
    Eur J Heart Fail; 2009 Dec; 11(12):1118-25. PubMed ID: 19926597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice.
    Dong F; Zhang X; Yang X; Esberg LB; Yang H; Zhang Z; Culver B; Ren J
    J Endocrinol; 2006 Jan; 188(1):25-36. PubMed ID: 16394172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO-dependent endothelial dysfunction in type II diabetes is aggravated by dyslipidemia and hypertension, but can be restored by angiotensin-converting enzyme inhibition and weight loss.
    Nevelsteen I; Van den Bergh A; Van der Mieren G; Vanderper A; Mubagwa K; Bult H; Herijgers P
    J Vasc Res; 2013; 50(6):486-97. PubMed ID: 24192582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury.
    Van der Mieren G; Nevelsteen I; Vanderper A; Oosterlinck W; Flameng W; Herijgers P
    Cardiovasc Diabetol; 2012 Aug; 11():89. PubMed ID: 22853195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
    Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
    Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer.
    Sakata S; Lebeche D; Sakata Y; Sakata N; Chemaly ER; Liang LF; Padmanabhan P; Konishi N; Takaki M; del Monte F; Hajjar RJ
    Mol Ther; 2006 May; 13(5):987-96. PubMed ID: 16503203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions.
    Van den Bergh A; Flameng W; Herijgers P
    Eur J Heart Fail; 2006 Dec; 8(8):777-83. PubMed ID: 16716661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity.
    Barouch LA; Gao D; Chen L; Miller KL; Xu W; Phan AC; Kittleson MM; Minhas KM; Berkowitz DE; Wei C; Hare JM
    Circ Res; 2006 Jan; 98(1):119-24. PubMed ID: 16339484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr.
    Lloyd DJ; McCormick J; Helmering J; Kim KW; Wang M; Fordstrom P; Kaufman SA; Lindberg RA; Véniant MM
    Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E496-505. PubMed ID: 18160459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of palmitate on Ca(2+) handling in adult control and ob/ob cardiomyocytes: impact of mitochondrial reactive oxygen species.
    Fauconnier J; Andersson DC; Zhang SJ; Lanner JT; Wibom R; Katz A; Bruton JD; Westerblad H
    Diabetes; 2007 Apr; 56(4):1136-42. PubMed ID: 17229941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice.
    Merx MW; Schäfer C; Westenfeld R; Brandenburg V; Hidajat S; Weber C; Ketteler M; Jahnen-Dechent W
    J Am Soc Nephrol; 2005 Nov; 16(11):3357-64. PubMed ID: 16177000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromium (D-phenylalanine)3 improves obesity-induced cardiac contractile defect in ob/ob mice.
    Dong F; Yang X; Sreejayan N; Ren J
    Obesity (Silver Spring); 2007 Nov; 15(11):2699-711. PubMed ID: 18070761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerobic interval training reduces inducible ventricular arrhythmias in diabetic mice after myocardial infarction.
    Rolim N; Skårdal K; Høydal M; Sousa MM; Malmo V; Kaurstad G; Ingul CB; Hansen HE; Alves MN; Thuen M; Haraldseth O; Brum PC; Slupphaug G; Loennechen JP; Stølen T; Wisløff U
    Basic Res Cardiol; 2015; 110(4):44. PubMed ID: 26112154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes.
    Severson DL
    Can J Physiol Pharmacol; 2004 Oct; 82(10):813-23. PubMed ID: 15573141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
    Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose-dependent enhancement of diabetic bladder contraction is associated with a rho kinase-regulated protein kinase C pathway.
    Nobe K; Yamazaki T; Tsumita N; Hashimoto T; Honda K
    J Pharmacol Exp Ther; 2009 Mar; 328(3):940-50. PubMed ID: 19050171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diabetic cardiomyopathy].
    Cohen A
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):479-86. PubMed ID: 7646266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus.
    Rijzewijk LJ; van der Meer RW; Smit JW; Diamant M; Bax JJ; Hammer S; Romijn JA; de Roos A; Lamb HJ
    J Am Coll Cardiol; 2008 Nov; 52(22):1793-9. PubMed ID: 19022158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energetic state is a strong regulator of sarcoplasmic reticulum Ca2+ loss in cardiac muscle: different efficiencies of different energy sources.
    Kuum M; Kaasik A; Joubert F; Ventura-Clapier R; Veksler V
    Cardiovasc Res; 2009 Jul; 83(1):89-96. PubMed ID: 19389722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.